TABLE 8.
Other neurological and psychiatric symptoms in VAERS COVID-19-related tinnitus reports.
| Symptom | Total # of cases * | Expected # of cases with tinnitus | Reported # of case with tinnitus ** | Observed/expectation ratio | p-value of χ 2 tests |
|---|---|---|---|---|---|
| Vision blurred | 6,623 | 118 | 341 | 2.88 | <0.00001 |
| Visual impairment | 3,701 | 66 | 227 | 3.43 | <0.00001 |
| Movement disorder | 1,581 | 28 | 20 | 0.71 | 0.101916 |
| Meniere’s disease | 78 | 1.34 | 22 | 15.75 | <0.00001 |
| Migraine | 8,507 | 152 | 262 | 1.72 | <0.00001 |
| Confusional state | 5,147 | 92 | 134 | 1.45 | 0.00004 |
| Memory impairment | 1,578 | 28 | 59 | 2.09 | <0.00001 |
| Anxiety | 7,681 | 138 | 262 | 1.90 | <0.00001 |
| Depression | 1,071 | 19 | 62 | 3.23 | <0.00000 |
*, total number of COVID-19, vaccine-related VAERS, cases reported by 4 December 2021, is 699,839; **, total number of COVID-19 vaccine-related tinnitus reports in the VAERS, database is 12,532.